PROSYNAP

Welcome to the Brand page for “PROSYNAP”, which is offered here for Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, and respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases; human pharmaceuticals for use as hemostatic agents;.

Its status is currently believed to be active. Its class is unavailable. “PROSYNAP” is believed to be currently owned by “Johnson & Johnson”.